Scientists have identified mutations in a gene that predict a high likelihood of relapse in children with acute lymphoblastic leukemia (ALL). Although the researchers caution that further research is needed to determine how changes in the gene, called IKZF1 or IKAROS, lead to leukemia relapse, the findings are likely to provide the basis for future
Tag: Health
A new online tool for calculating colorectal cancer risk in men and women age 50 or older was launched today, based on a new risk-assessment model developed by researchers at the National Cancer Institute, part of the National Institutes of Health. This new tool may assist health care providers and their patients in making informed
The NCI supports an average of over 1,300 clinical trials a year in the areas of prevention, screening, diagnostics, treatment, quality of life, supportive care, and genetics. Conducting clinical trials across multiple institutions in numerous locations requires a great deal of coordination to insure quality and consistency throughout all aspects of the trial, triggering the
The National Cancer Institute oversees the U.S. National Cancer Program and is also involved in the promotion of global health and cancer control. The National Cancer Act of 1971 directed the NCI to collect, analyze and disseminate research on the prevention, diagnosis and treatment of cancer, to share cancer research information globally, and to support